Insider Trading Summary for Enanta Pharmaceuticals Inc (ENTA): Three Months

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
14-Feb-24 8:00 PM View:	12-Feb-24 Payment of Exercise ($19.66K)	Luly Jay R. President and CEO Director		Enanta Pharmaceuticals Inc - ENTA	0% 806.79K to 810.61K	0	0	--	--	Show Txns Hide Txns

14-Feb-24 8:09 PM View:	12-Feb-24 Payment of Exercise ($12.07K)	Mellett Paul J Chief Fin. & Admin Officer		Enanta Pharmaceuticals Inc - ENTA	3% 93.55K to 95.9K	0	0	--	--	Show Txns Hide Txns

14-Feb-24 8:12 PM View:	12-Feb-24 Payment of Exercise ($13.40K)	Or Yat Sun Chief Scientific Officer		Enanta Pharmaceuticals Inc - ENTA	1% 370.69K to 373.3K	0	0	--	--	Show Txns Hide Txns

14-Feb-24 8:15 PM View:	12-Feb-24 Payment of Exercise ($9.37K)	Rottinghaus Scott T. Chief Medical Officer		Enanta Pharmaceuticals Inc - ENTA	7% 26.47K to 28.29K	0	0	--	--	Show Txns Hide Txns

27-Feb-24 6:31 PM View:	26-Feb-24 Option Exercise $46.63K	Gardiner Nathaniel S. Chief Legal Officer		Enanta Pharmaceuticals Inc - ENTA	7% 104.08K to 111.61K	0	0	--	--	Show Txns Hide Txns

14-Feb-24 8:21 PM View:	12-Feb-24 Payment of Exercise ($12.07K)	Kieffer Tara Lynn Chief Product Strategy Officer		Enanta Pharmaceuticals Inc - ENTA	6% 37.26K to 39.61K	0	0	--	--	Show Txns Hide Txns

14-Feb-24 8:23 PM View:	12-Feb-24 Payment of Exercise ($12.07K)	Luu Brendan Chief Business Officer		Enanta Pharmaceuticals Inc - ENTA	6% 36.74K to 39.08K	0	0	--	--	Show Txns Hide Txns

Buy:	0	--
Sell:	0	--